Steven Cohen’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Steven Cohen’s Portfolio ONCE Stock Details ONCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-100,000	Closed	-$11.4M	–	1650
2019 Q1	$11.4M	Buy	100,000 +68,382	+216%	+$5.03M	0.05%	367
2018 Q4	$1.24M	Buy	+31,618	New	+$1.37M	0.01%	789
2018 Q2	–	Sell	-38,500	Closed	-$2.97M	–	1273
2018 Q1	$2.56M	Buy	+38,500	New	+$2.22M	0.01%	700
2017 Q4	–	Sell	-19,802	Closed	-$1.77M	–	1181
2017 Q3	$1.77M	Sell	19,802 -26,698	-57%	-$2.03M	0.01%	695
2017 Q2	$2.78M	Buy	+46,500	New	+$2.6M	0.02%	603

Other funds holding ONCE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Steven Cohen's ONCE Position: Q2 2019 in Review

Steven Cohen sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q2 2019, closing a stake of 100,000 shares — an estimated $11.4M sold.

Steven Cohen first reported a position in ONCE in Q2 2017 and held it in 5 quarters. The position peaked at $11.4M in Q1 2019. 194 funds tracked by Wall St. Rank hold ONCE as of Q2 2019.

Steven Cohen reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
Steven Cohen sold 100,000 Spark Therapeutics, Inc. Common Stock shares in Q2 2019, an estimated $11.4M.
Steven Cohen first reported a position in Spark Therapeutics, Inc. Common Stock in Q2 2017 and held it in 5 quarters.
Steven Cohen's Spark Therapeutics, Inc. Common Stock position peaked at $11.4M in Q1 2019.
194 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q2 2019.

Based on Point72 Asset Management's 13F filing for Q2 2019, filed 14 Aug 2019.